NVP-KFA115   Click here for help

GtoPdb Ligand ID: 14673

Synonyms: example 31 [WO2023178181] | KFA115
Compound class: Synthetic organic
Comment: NVP-KFA115 is a molecular glue degrader that promotes degradation of the Ikaros zinc finger transcription factors IKZF2 and IKZF4 via recruitment of the cereblon E3 ubiquitin ligase. It is one of the compounds claimed in patent [1].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 78.95
Molecular weight 439.55
XLogP 1.09
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCOC1CN(C1)[C@H]2CCCC[C@@H]2CC3=CC=C4C(=C3)CN(C5CCC(=O)NC5=O)C4=O
Isomeric SMILES C1C[C@H](CC=2C=CC=3C(=O)N(C4CCC(=O)NC4=O)CC3C2)[C@@H](N5CC(OCC)C5)CC1
InChI InChI=1S/C25H33N3O4/c1-2-32-19-14-27(15-19)21-6-4-3-5-17(21)11-16-7-8-20-18(12-16)13-28(25(20)31)22-9-10-23(29)26-24(22)30/h7-8,12,17,19,21-22H,2-6,9-11,13-15H2,1H3,(H,26,29,30)/t17-,21+,22?/m1/s1
InChI Key FKCCFDNDLIDANT-HWWMDGIVSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
KFA115 was progressed as a clinical candidate for application as therapeutic for advanced solid tumours.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05544929 A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers Phase 1 Interventional Novartis